about
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.Coming of Age: CD96 Emerges as Modulator of Immune Responses.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
CD155, an onco-immunologic molecule in human tumors.
@en
CD155, an onco-immunologic molecule in human tumors.
@nl
type
label
CD155, an onco-immunologic molecule in human tumors.
@en
CD155, an onco-immunologic molecule in human tumors.
@nl
prefLabel
CD155, an onco-immunologic molecule in human tumors.
@en
CD155, an onco-immunologic molecule in human tumors.
@nl
P2093
P2860
P921
P356
P1433
P1476
CD155, an onco-immunologic molecule in human tumors.
@en
P2093
P2860
P304
P356
10.1111/CAS.13324
P5008
P577
2017-07-21T00:00:00Z
2017-10-01T00:00:00Z